| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736204 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IRS2 mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736204 | 6480464 | Estradiol promotes the reaction [Progesterone results in increased expression of IRS2 mRNA]; more ... | CTD | PMID:15949379 |
| 17beta-estradiol | decreases expression | ISO | RGD:736204 | 6480464 | Estradiol results in decreased expression of IRS2 mRNA | CTD | PMID:19167446 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736204 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of IRS2 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases phosphorylation | ISO | RGD:736204 | 6480464 | Estradiol results in increased phosphorylation of IRS2 protein | CTD | PMID:15949379 |
| 17beta-estradiol | increases expression | ISO | RGD:736204 | 6480464 | Estradiol results in increased expression of IRS2 mRNA; more ... | CTD | PMID:15949379 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of IRS2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69316 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IRS2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69316 | 6480464 | Tetrachlorodibenzodioxin affects the expression of IRS2 mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:69316 | 6480464 | 2,4-dinitrotoluene affects the expression of IRS2 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:69316 | 6480464 | 2,6-dinitrotoluene affects the expression of IRS2 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:736204 | 6480464 | beta-methylcholine affects the expression of IRS2 mRNA | CTD | PMID:21179406 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA; more ... | CTD | PMID:16054899 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:736204 | 6480464 | decitabine results in increased expression of IRS2 mRNA | CTD | PMID:16367923 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736204 | 6480464 | Tretinoin results in increased expression of IRS2 mRNA | CTD | PMID:16249480 |
| ammonium chloride | affects expression | ISO | RGD:69316 | 6480464 | Ammonium Chloride affects the expression of IRS2 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of IRS2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:736204 | 6480464 | Benzo(a)pyrene results in increased expression of IRS2 mRNA | CTD | PMID:22316170 |
| bisphenol A | decreases expression | ISO | RGD:69316 | 6480464 | bisphenol A results in decreased expression of IRS2 protein | CTD | PMID:22101236 |
| candesartan | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; more ... | CTD | PMID:21255808 |
| chlorpromazine | multiple interactions | ISO | RGD:69316 | 6480464 | Chlorpromazine results in decreased expression of and results in increased degradation of IRS2 protein | CTD | PMID:18308779 |
| chlorpromazine | multiple interactions | ISO | RGD:69316 | 6480464 | Chlorpromazine results in decreased expression of and results in decreased phosphorylation of IRS2 protein | CTD | PMID:17512020 |
| copper atom | multiple interactions | ISO | RGD:736204 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of IRS2 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:736204 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of IRS2 mRNA | CTD | PMID:20971185 |
| copper(II) chloride | increases expression | ISO | RGD:736204 | 6480464 | cupric chloride results in increased expression of IRS2 mRNA | CTD | PMID:17211630 |
| coumestrol | decreases expression | ISO | RGD:736204 | 6480464 | Coumestrol results in decreased expression of IRS2 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:736204 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | ISO | RGD:736204 | 6480464 | Asbestos, Crocidolite results in increased expression of IRS2 mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | ISO | RGD:736204 | 6480464 | Cyclosporine results in increased expression of IRS2 mRNA | CTD | PMID:20106945 |
| D-glucose | increases phosphorylation | ISO | RGD:736204 | 6480464 | Glucose results in increased phosphorylation of IRS2 protein | CTD | PMID:10430617 |
| D-glucose | increases abundance | EXP | | 6480464 | IRS2 gene mutant form results in increased abundance of Glucose | CTD | PMID:20028942 |
| dexamethasone | multiple interactions | EXP | | 6480464 | EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA]; more ... | CTD | PMID:16054899 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of IRS2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:69316 | 6480464 | Dibutyl Phthalate results in increased expression of IRS2 mRNA | CTD | PMID:17379624 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of IRS2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| etoposide | affects response to substance | ISO | RGD:736204 | 6480464 | IRS2 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 |
| fructose | decreases expression | ISO | RGD:69316 | 6480464 | Fructose results in decreased expression of IRS2 mRNA | CTD | PMID:19165636 |
| fructose | multiple interactions | ISO | RGD:69316 | 6480464 | NOS3 protein inhibits the reaction [Fructose results in decreased expression of IRS2 protein] | CTD | PMID:19008412 |
| fructose | decreases expression | ISO | RGD:69316 | 6480464 | Fructose results in decreased expression of IRS2 protein | CTD | PMID:19008412 |
| genistein | decreases expression | ISO | RGD:736204 | 6480464 | Genistein results in decreased expression of IRS2 mRNA | CTD | PMID:19371625 |
| glucose | increases phosphorylation | ISO | RGD:736204 | 6480464 | Glucose results in increased phosphorylation of IRS2 protein | CTD | PMID:10430617 |
| glucose | increases abundance | EXP | | 6480464 | IRS2 gene mutant form results in increased abundance of Glucose | CTD | PMID:20028942 |
| indole-3-methanol | multiple interactions | ISO | RGD:69316 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA | CTD | PMID:22129741 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of IRS2 mRNA | CTD | PMID:21829687 |
| LY294002 | multiple interactions | ISO | RGD:736204 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [IAPP protein promotes the reaction [rosiglitazone results in increased expression of IRS2 protein]] | CTD | PMID:16204373 |
| methylmercury chloride | affects expression | ISO | RGD:69316 | 6480464 | methylmercuric chloride affects the expression of IRS2 mRNA | CTD | PMID:20864626 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69316 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | affects expression | ISO | RGD:69316 | 6480464 | Diethylnitrosamine affects the expression of IRS2 mRNA | CTD | PMID:20387270 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69316 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69316 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IRS2 mRNA | CTD | PMID:18164116 |
| oleic acid | multiple interactions | ISO | RGD:69316 | 6480464 | IRS2 inhibits the reaction [Oleic Acid results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:14604813 |
| palmitic acid | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Palmitic Acid results in decreased phosphorylation of IRS2 protein]; more ... | CTD | PMID:21255808 |
| palmitic acid | decreases phosphorylation | EXP | | 6480464 | Palmitic Acid results in decreased phosphorylation of IRS2 protein | CTD | PMID:21255808 |
| paracetamol | increases expression | ISO | RGD:736204 | 6480464 | Acetaminophen results in increased expression of IRS2 mRNA | CTD | PMID:21420995 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of IRS2 mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of IRS2 mRNA | CTD | PMID:19270015 PMID:23091169 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of IRS2 mRNA | CTD | PMID:18445702 |
| piroxicam | decreases expression | ISO | RGD:736204 | 6480464 | Piroxicam results in decreased expression of IRS2 mRNA | CTD | PMID:21858171 |
| progesterone | multiple interactions | ISO | RGD:736204 | 6480464 | Estradiol promotes the reaction [Progesterone results in increased expression of IRS2 mRNA]; more ... | CTD | PMID:15949379 |
| progesterone | increases expression | ISO | RGD:736204 | 6480464 | Progesterone results in increased expression of IRS2 mRNA | CTD | PMID:15949379 PMID:17404688 |
| progesterone | increases phosphorylation | ISO | RGD:736204 | 6480464 | Progesterone results in increased phosphorylation of IRS2 protein | CTD | PMID:15949379 |
| progesterone | increases expression | ISO | RGD:736204 | 6480464 | Progesterone results in increased expression of IRS2 protein | CTD | PMID:15949379 |
| progesterone | increases expression | ISO | RGD:736204 | 6480464 | Progesterone results in increased expression of IRS2 mRNA | CTD | PMID:17404688 PMID:15949379 |
| progesterone | multiple interactions | ISO | RGD:736204 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of IRS2 mRNA | CTD | PMID:17404688 |
| ranitidine | multiple interactions | ISO | RGD:69316 | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of IRS2 mRNA] | CTD | PMID:16415329 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IRS2 gene mutant form results in increased activity of PTPN1 protein]; more ... | CTD | PMID:20028942 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IRS2 mRNA]; more ... | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:736204 | 6480464 | rosiglitazone results in increased expression of IRS2 protein | CTD | PMID:16204373 |
| rosiglitazone | multiple interactions | ISO | RGD:736204 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [IAPP protein promotes the reaction [rosiglitazone results in increased expression of IRS2 protein]] | CTD | PMID:16204373 |
| testosterone | increases expression | ISO | RGD:736204 | 6480464 | Testosterone results in increased expression of IRS2 mRNA | CTD | PMID:21632903 |
| tetrachloromethane | decreases expression | ISO | RGD:69316 | 6480464 | Carbon Tetrachloride results in decreased expression of IRS2 protein | CTD | PMID:12629582 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [IRS2 gene mutant form results in increased activity of PTPN1 protein]; more ... | CTD | PMID:20028942 |
| troglitazone | increases expression | ISO | RGD:736204 | 6480464 | troglitazone results in increased expression of IRS2 mRNA | CTD | PMID:19140230 |
| ursodeoxycholic acid | increases expression | ISO | RGD:69316 | 6480464 | Ursodeoxycholic Acid results in increased expression of IRS2 mRNA | CTD | PMID:15885361 |
| zinc atom | decreases expression | ISO | RGD:736204 | 6480464 | Zinc results in decreased expression of IRS2 protein | CTD | PMID:19913001 |
| zinc(0) | decreases expression | ISO | RGD:736204 | 6480464 | Zinc results in decreased expression of IRS2 protein | CTD | PMID:19913001 |